Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade

被引:0
作者
Chih-Chieh Ko
Shu-Yein Ho
Po-Hong Liu
Chia-Yang Hsu
Cheng-Yuan Hsia
Yi-Hsiang Huang
Chien-Wei Su
Hao-Jan Lei
Rheun-Chuan Lee
Ming-Chih Hou
Teh-Ia Huo
机构
[1] Taipei Veterans General Hospital,Department of Medicine
[2] National Yang Ming Chiao Tung University,School of Medicine
[3] Min-Sheng General Hospital,Division of Gastroenterology and Hepatology
[4] University of Texas Southwestern Medical Center,Department of Internal Medicine
[5] VA Sierra Nevada Health Care System,Institute of Clinical Medicine
[6] National Yang Ming Chiao Tung University,Department of Surgery
[7] Taipei Veterans General Hospital,Department of Radiology
[8] Taipei Veterans General Hospital,Department of Medical Research
[9] Taipei Veterans General Hospital,Institute of Pharmacology
[10] National Yang Ming Chiao Tung University School of Medicine,undefined
来源
International Journal of Clinical Oncology | 2022年 / 27卷
关键词
Dual HBV/HCV infection; Hepatocellular carcinoma; ALBI grade; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:739 / 748
页数:9
相关论文
共 50 条
  • [21] Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis
    Gauri Mishra
    Ammar Majeed
    Anouk Dev
    Guy D. Eslick
    David J. Pinato
    Hirofumi Izumoto
    Atsushi Hiraoka
    Teh-Ia Huo
    Po-Hong Liu
    Philip J. Johnson
    Stuart K. Roberts
    Journal of Gastrointestinal Cancer, 2023, 54 : 420 - 432
  • [22] Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study
    Yajuan J Liu
    Yang Zhou
    Matthew M Yeh
    Molecular Cytogenetics, 7
  • [23] Recurrent genetic alterations in hepatitis C-associated hepatocellular carcinoma detected by genomic microarray: a genetic, clinical and pathological correlation study
    Liu, Yajuan J.
    Zhou, Yang
    Yeh, Matthew M.
    MOLECULAR CYTOGENETICS, 2014, 7
  • [24] Albumin-bilirubin grade as a prognostic factor of hepatocellular carcinoma after treatment with orthotopic liver transplantation
    Liao, Jianhua
    Liu, Jingting
    Li, Changcan
    Fan, Junwei
    Wang, Zhaowen
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1457 - 1465
  • [25] The role of albumin-bilirubin grade in determining the outcomes of patients with very early-stage hepatocellular carcinoma
    Chang, Chung-Yu
    Wei, Cheng-Yi
    Chen, Ping-Hsien
    Hou, Ming-Chih
    Chao, Yee
    Chau, Gar-Yang
    Lee, Rheun-Chuan
    Huang, Yi-Hsiang
    Su, Yu-Hui
    Wu, Jaw-Ching
    Su, Chien-Wei
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2021, 84 (02) : 136 - 143
  • [26] Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization
    Gui, Bin
    Weiner, Ashley A.
    Nosher, John
    Lu, Shou-En
    Foltz, Gretchen M.
    Hasan, Omar
    Kim, Seung K.
    Gendel, Vyacheslav
    Mani, Naganathan B.
    Carpizo, Darren R.
    Saad, Nael E.
    Kennedy, Timothy J.
    Zuckerman, Darryl A.
    Olsen, Jeffrey R.
    Parikh, Parag J.
    Jabbour, Salma K.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (09): : 861 - 866
  • [27] A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation
    Huang, Jingzhi
    Cui, Wei
    Xie, Xiaohua
    Lin, Ke
    Jin, Dongdong
    Xie, Xiaoyan
    Zhuang, Bowen
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2023, 40 (01)
  • [28] Clinical Characteristics and Surgical Outcome in Hepatocellular Carcinoma without Hepatitis B Virus Surface Antigen or Hepatitis C Virus Antibody
    Kuniya Tanaka
    Hiroshi Shimada
    Kenichi Matsuo
    Yasuhiko Nagano
    Itaru Endo
    Shinji Togo
    Annals of Surgical Oncology, 2007, 14 : 1170 - 1181
  • [29] Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody
    Tanaka, Kuniya
    Shimada, Hiroshi
    Matsuo, Kenichi
    Nagano, Yasuhiko
    Endo, Itaru
    Togo, Shinji
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1170 - 1181
  • [30] Comparison of new prognostic systems for patients with resectable hepatocellular carcinoma: Albumin-Bilirubin grade and Albumin-Indocyanine Green Evaluation grade
    Honmyo, Naruhiko
    Kobayashi, Tsuyoshi
    Hamaoka, Michinori
    Kohashi, Toshihiko
    Abe, Tomoyuki
    Oishi, Koichi
    Tazawa, Hirofumi
    Imaoka, Yasuhiro
    Akita, Tomoyuki
    Tanaka, Junko
    Ohdan, Hideki
    HEPATOLOGY RESEARCH, 2019, 49 (10) : 1218 - 1226